Related Experiment Video
Updated: Sep 13, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
HIV Complicated with Talaromyces Marneffei Multisystem Infection: A Case Report and Literature Review
Guomin Zhang1, Guangrong Wu1, Yuanyuan Xu1
1Department of Radiology, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, People's Republic of China.
This case study shows a disseminated Talaromyces marneffei (TM) infection in an HIV patient with neurological symptoms. Early diagnosis and treatment led to significant recovery and lesion resolution.
Area of Science:
- Mycology
- Infectious Diseases
- Neurology
Background:
- Human Immunodeficiency Virus (HIV) infection compromises the immune system, increasing susceptibility to opportunistic infections.
- Talaromyces marneffei (TM) infection is an endemic mycosis prevalent in Southeast Asia, posing a significant threat to immunocompromised individuals.
Observation:
- A hospitalized HIV patient presented with neurological symptoms including dizziness, headache, and lip numbness.
- Neuroimaging revealed disseminated lesions across the brain, spinal cord, lungs, and mesenteric lymph nodes.
- Cerebrospinal fluid analysis and genetic testing confirmed systemic TM infection.
Findings:
- Intravenous amphotericin B treatment for 10 days resulted in symptomatic improvement and discharge.
- Combination antiretroviral therapy (Bictegravir/Emtricitabine/Tenofovir alafenamide) and oral itraconazole prophylaxis were initiated post-discharge.
- One-year follow-up imaging showed near-complete resolution of disseminated TM lesions.
Implications:
- Disseminated TM infection should be considered in HIV patients presenting with neurological symptoms, especially in endemic areas.
- Characteristic radiological patterns can aid in early diagnosis of systemic TM infection.
- Prompt diagnosis and integrated treatment (antifungal and antiretroviral therapy) are crucial for favorable outcomes in HIV-associated TM infections.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Endocarditis III: Medical Management

